Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alpine Immune Sciences Inc
(NQ:
ALPN
)
64.59
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6
Open
64.59
Bid (Size)
64.00 (200)
Ask (Size)
65.01 (2)
Prev. Close
64.59
Today's Range
64.59 - 64.59
52wk Range
6.710 - 64.72
Shares Outstanding
23,914,879
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sarepta Therapeutics Stock Shows Improved Technical Strength
April 29, 2024
The Relative Strength (RS) Rating for Sarepta Therapeutics stock headed into a new percentile Monday, as it got a lift from 70 to 73.
Via
Investor's Business Daily
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
April 26, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
YTD
+239.95%
+239.95%
1 Month
+60.59%
+60.59%
3 Month
+151.03%
+151.03%
6 Month
+530.76%
+530.76%
1 Year
+762.35%
+762.35%
More News
Read More
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
April 26, 2024
Via
Benzinga
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
April 23, 2024
Via
The Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
April 22, 2024
Via
The Motley Fool
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 4/16
April 16, 2024
Via
Investor Brand Network
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Via
The Motley Fool
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
April 18, 2024
Via
The Motley Fool
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?
April 15, 2024
Via
InvestorPlace
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
April 15, 2024
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
April 13, 2024
Via
The Motley Fool
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
April 12, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review
April 12, 2024
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Stocks Surge, Goldgasms To Record High After "Adjusted" PPI Sparks Buying Frenzy
April 11, 2024
Via
Talk Markets
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
April 11, 2024
Via
Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
April 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Near Top of Volume Charts in Thursday Trading
April 11, 2024
Via
Investor Brand Network
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Records 52-Week High Thursday Morning
April 11, 2024
Via
Investor Brand Network
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Via
InvestorPlace
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 11, 2024
Via
Investor's Business Daily
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 11, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.